Pay Our Correctional Officers Fairly Act

Senior Citizens Tax Elimination Act

Protect Lifesaving Anesthesia Care for Veterans Act of 2023

To designate the facility of the United States Postal Service located at 220 North Hatcher Avenue in Purcellville, Virginia, as the "Secretary of State Madeleine Albright Post Office Building".

To name the Department of Veterans Affairs community-based outpatient clinic in Lynchburg, Virginia, as the "Private First Class Desmond T. Doss VA Clinic".

SHIP Act Stop Harboring Iranian Petroleum Act

Pandemic is Over Act This bill terminates the COVID-19 public health emergency that was declared on January 31, 2020, on the date of the bill's enactment.

END CELLS in CELLS Act Eliminate Non-approved Devices and Contraband Electronics Limiting Links to Society in Confined Environments for Longer Lasting Safety Act

Methane Reduction and Economic Growth Act

Protecting America’s Distribution Transformer Supply Chain Act

Support And Value Expectant Moms and Babies Act of 2023 or the SAVE Moms and Babies Act of 2023 This bill prohibits the Food and Drug Administration (FDA) from approving any new drug (either as a brand-name drug or a generic) intended to terminate a pregnancy and imposes additional restrictions on such drugs that are already approved. Under the bill, an already-approved drug intended to terminate a pregnancy may be dispensed to a patient only with a prescription. Furthermore, the FDA may not approve any labeling change that would authorize (1) using the drug after 70 days of gestation, or (2) dispensing the drug by any means other than in-person administration by the prescribing health care practitioner. The FDA must also impose additional restrictions on such already-approved drugs, including by (1) requiring the prescribing health care practitioner to receive a special certification, (2) prohibiting the practitioner from also acting as the dispensing pharmacist, and (3) requiring the practitioner to have the ability to provide surgical intervention to the patient. The bill also rescinds any investigational use exemption already granted to such a drug if the bill would have prohibited the FDA from granting the exemption. (Currently, the FDA may grant an exemption to certain market approval requirements if a drug is intended solely for use in safety and effectiveness investigations.)

Fairness for Patient Medications Act

BROADBAND Leadership Act Barriers and Regulatory Obstacles Avoids Deployment of Broadband Access and Needs Deregulatory Leadership Act

Federal Bird Safe Buildings Act of 2023

RECONNECTIONS Act of 2023 Reauthorizing the Creating Opportunities that Necessitate New and Enhanced Connections That Improve Opioid Navigation Strategies Act of 2023